Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. (2018)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2018-000325
PubMed Identifier: 30167310
Publication URI: http://europepmc.org/abstract/MED/30167310
Type: Journal Article/Review
Volume: 5
Parent Publication: BMJ open respiratory research
Issue: 1
ISSN: 2052-4439